Heart 1998;79:113-114 ( February )
Editorial
Cholesterol embolisation
| The first 150 words of the full text of this article appear below. |
The clinical consequences of cholesterol embolisation vary considerably. Patients may be completely asymptomatic when the diagnosis is made coincidentally at renal biopsy or they may present with a distinct clinical syndrome that is associated with a high mortality. As only a minority of patients sustaining cholesterol emboli are recognised clinically, the actual incidence and pathophysiology of the syndrome remains uncertain.
Typical features of the clinical syndrome include livedo reticularis and painful focal digital ischaemia, characteristically with a normal peripheral arterial pulse (the purple toe syndrome). Other clinical features include retinal embolisation, renal failure (usually with baseline renal impairment), labile blood pressure, and abdominal symptoms that may vary depending on which organ is involved.1
Tissue biopsy is the diagnostic investigation of choice. Skin or muscle
biopsy can be used but where possible the affected organ should be
biopsied. The characteristic pathological lesion is occlusion of
affected arterioles by luminal needle shaped
This article has been cited by other articles:
-
Filip, J. R., Dillon, R. S.
(2008). Treatment of End-Stage "Trash Feet" With the End-Diastolic Pneumatic Boot. ANGIOLOGY
59: 214-219
[Abstract]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
